Total Payments
$13,746
2024 Payments
$1,318
Companies
55
Transactions
660
Medicare Patients
1,733
Medicare Billing
$194,187
Payment Breakdown by Category
Food & Beverage$13,563 (98.7%)
Education$182.32 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,563 | 651 | 98.7% |
| Education | $182.32 | 9 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,615 | 79 | $0 (2024) |
| Amgen Inc. | $1,370 | 52 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,053 | 75 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $913.24 | 31 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $677.93 | 41 | $0 (2024) |
| Lilly USA, LLC | $671.49 | 28 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $612.44 | 29 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $588.69 | 24 | $0 (2021) |
| Avanir Pharmaceuticals, Inc. | $450.50 | 22 | $0 (2022) |
| ABBVIE INC. | $434.14 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,318 | 53 | AstraZeneca Pharmaceuticals LP ($390.31) |
| 2023 | $1,953 | 81 | Novo Nordisk Inc ($432.00) |
| 2022 | $1,179 | 60 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($155.83) |
| 2021 | $1,821 | 92 | AbbVie Inc. ($290.19) |
| 2020 | $1,331 | 73 | Novo Nordisk Inc ($243.96) |
| 2019 | $1,661 | 66 | Amgen Inc. ($275.32) |
| 2018 | $1,980 | 96 | Amgen Inc. ($333.71) |
| 2017 | $2,503 | 139 | Merck Sharp & Dohme Corporation ($257.78) |
All Payment Transactions
660 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 11/07/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Diabetes Care | ||||||
| 11/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/22/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Bone Health | ||||||
| 10/02/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/26/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Endocrinology | ||||||
| 09/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Obesity | ||||||
| 09/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Inflammation | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/19/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Obesity | ||||||
| 08/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: Inflammation | ||||||
| 08/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Oncology | ||||||
| 07/29/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Endocrinology | ||||||
| 07/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/01/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Inflammation | ||||||
| 05/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Obesity | ||||||
| 05/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 537 | 1,223 | $104,171 | $56,852 |
| 2022 | 11 | 373 | 803 | $77,480 | $44,708 |
| 2021 | 10 | 375 | 746 | $79,670 | $46,668 |
| 2020 | 11 | 448 | 904 | $88,967 | $45,960 |
Total Patients
1,733
Total Services
3,676
Medicare Billing
$194,187
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 124 | 380 | $38,000 | $22,105 | 58.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 73 | 73 | $10,280 | $8,707 | 84.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 90 | $9,270 | $5,286 | 57.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 51 | $7,650 | $4,582 | 59.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 63 | 63 | $6,300 | $3,420 | 54.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 88 | $6,600 | $3,382 | 51.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 18 | $5,382 | $2,324 | 43.2% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 11 | 75 | $4,125 | $2,183 | 52.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 13 | 50 | $3,750 | $1,776 | 47.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 50 | 127 | $6,985 | $1,295 | 18.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 15 | 20 | $3,000 | $1,198 | 39.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 33 | 49 | $735.00 | $292.10 | 39.7% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 26 | 30 | $750.00 | $275.72 | 36.8% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 14 | 62 | $1,250 | $22.67 | 1.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 30 | 47 | $94.00 | $4.60 | 4.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 118 | 352 | $35,200 | $21,570 | 61.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 142 | $14,626 | $7,638 | 52.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 60 | 60 | $8,460 | $7,460 | 88.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 19 | $5,681 | $2,799 | 49.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 30 | $4,500 | $2,784 | 61.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 17 | 22 | $3,300 | $1,201 | 36.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 29 | 71 | $3,905 | $745.93 | 19.1% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 31 | 48 | $1,200 | $414.32 | 34.5% |
| 81003 | Automated urinalysis test | Office | 2022 | 18 | 22 | $264.00 | $48.77 | 18.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 14 | 15 | $300.00 | $44.10 | 14.7% |
About Dr. James Ensor, MD
Dr. James Ensor, MD is a Internal Medicine healthcare provider based in Germantown, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1205811247.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Ensor, MD has received a total of $13,746 in payments from pharmaceutical and medical device companies, with $1,318 received in 2024. These payments were reported across 660 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($13,563).
As a Medicare-enrolled provider, Ensor has provided services to 1,733 Medicare beneficiaries, totaling 3,676 services with total Medicare billing of $194,187. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Germantown, TN
- Active Since 12/13/2005
- Last Updated 04/09/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205811247
Products in Payments
- Ozempic (Drug) $855.39
- Repatha (Biological) $601.23
- XARELTO (Drug) $523.42
- NUEDEXTA (Drug) $482.63
- FARXIGA (Drug) $447.94
- BELSOMRA (Drug) $384.89
- CYCLOSET (Drug) $382.25
- Vascepa (Drug) $362.20
- ENTRESTO (Drug) $359.35
- DALVANCE (Drug) $327.13
- LEQVIO (Drug) $318.58
- Otezla (Drug) $314.94
- BREZTRI (Drug) $286.72
- JANUVIA (Drug) $254.35
- SOLIQUA (Drug) $239.85
- Livalo (Drug) $239.10
- ELIQUIS (Drug) $236.18
- TRULICITY (Drug) $227.91
- DUPIXENT (Drug) $226.95
- Prolia (Biological) $210.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Germantown
Dr. David Lan, Md, MD
Internal Medicine — Payments: $221,102
Internal Medicine $221,102
Dr. Ari Vanderwalde, M.d, M.D
Internal Medicine — Payments: $48,555
Internal Medicine $48,555
Dr. John Trujillo, M.d, M.D
Internal Medicine — Payments: $28,212
Internal Medicine $28,212
Dr. Vinu Ganti, Md, MD
Internal Medicine — Payments: $20,803
Internal Medicine $20,803
Dr. Mark Goldstein, Md, MD
Internal Medicine — Payments: $20,002
Internal Medicine $20,002
Yaser Cheema, Md, MD
Internal Medicine — Payments: $12,560
Internal Medicine $12,560